Fig. 6
From: Carrier-free multifunctional nanomedicine for intraperitoneal disseminated ovarian cancer therapy
The biosafety evaluation of ACaT in vitro and in vivo. Cell viability of A HK2 cells and B HMrSVS cells cultured with various concentrations of ACaT for 24 and 48 h, respectively. C The photographs of human erythrocytes treated with ACaT at different concentrations. Samples 1–10: negative control (NS), eight different concentrations of ACaT, positive control (dd H2O). D Hemolysis rate of ACaT, NS and dd H2O. E H&E staining of tissue slice of main organs in PBS, NaALN, THZ1 and ACaT groups (n = 3). Scale bar, 50 μm